Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
On , Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
Dr. Waqqas Tai is a cancer doctor who often shares health advice online. He recently revealed what the five most "lethal" ...
This article presents a comprehensive overview of the molecular mechanisms underlying the anti-cancer properties of ICA, and further highlights recent progress in use of ICA in cancer research, ...
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
BuzzFeed on MSN1h
These Are The 5 Biggest Early Warning Signs Of Liver DamageIf you believe you have any liver damage symptoms, it’s important to discuss this with your provider. Other symptoms include ...
A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...
CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...
It makes knowing the signs of a developing medical condition and taking steps to prevent it all the more valid. Below, we discuss colorectal cancer risk factors, its signs and things you can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback